Third, GLP-1 receptor agonists (particularly the shorter-acting agents) delay gastric emptying, thus delaying carbohydrate absorption and promoting satiety
Wegovy pens, on the other hand, each contain a single dose
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics
While rare, GLP-1 receptor agonists can have serious side effects, including gastrointestinal issues, thyroid cancer, pancreatitis, liver injury and kidney problems
If constipation persists, consult your healthcare provider for personalized advice and potential adjustments to your treatment plan